In the triple-negative breast cancer (TNBC) cell line MDA-MB-231, where PC-PLC was expressed at two- to six-fold higher concentrations than basal levels, treatment with D609 halted proliferation, caused progressive reversal of mesenchymal traits, and reduced motility of the cancer cells [4]. The gene discussed is HSPG2; the disease is cancer.